Skip to main content
. 2013 Aug 14;28(5):515–524. doi: 10.3904/kjim.2013.28.5.515

Table 4.

Previous reports of second-line chemotherapy

graphic file with name kjim-28-515-i004.jpg

RR, response rate; PFS, progression-free survival; TTP, time-to-progression; OS, overall survival; GEM, gemcitabine; CDDP, cisplatin; FAM, 5-fluorouracil + doxorubicin + mitomycin-C.